Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can rehab at home beat the clinic for COPD patients?

NCT ID NCT03453606

Symptom relief Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether doing breathing and exercise training at home works as well as doing it at a rehab center for people with chronic obstructive pulmonary disease (COPD). The goal was to see if home rehab could improve exercise tolerance just as much, while also being cheaper and more convenient. The study planned to include 188 adults with moderate to severe COPD, but it was stopped early, so the full results are not available.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
respiratory rehabilitation (home-based or center-based)
What this could lead to
If successful, this could show that home-based rehabilitation is as effective as center-based care, offering a more convenient and cost-effective option for COPD patients.
What could go wrong
The trial was terminated early, so results may be incomplete. Home-based rehab may not provide the same supervision or equipment as center-based programs, potentially affecting outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

188 people

The number who actually took part.

Started

Oct 2018

Finished

Sep 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria:According to HAS recommendations, SPLF, ERS / ATS (3) (18) (19) can be included any patient, over 18 years old, with stage II - III - IV COPD presenting disabling dyspnoea in activities of daily living, and / or in the course of acute exacerbation of COPD (EABPCO), with no other respiratory pathology diagnosed. Exclusion Criteria: According to the recommendations, HAS, SPLF, ERS / ATS will not be included any patient having : * co-morbidities including unstabilized cardiovascular disease, * significant cognitive disorders: patients with a history of pathologies neurodegenerative with loss of mental faculties (example: Alzheimer) * psychiatric disorders: patients with impaired judgment and perception * neurological or orthopedic disorders that do not allow the realization of physical activities Also, will not be included, the patient (s): * waiting for lung transplantation, * pregnant or nursing, * in an emergency situation * unable to receive enlightened information, * unable to participate in the entire study, * not covered by the social security scheme, * refusing to sign the consent,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease

Contacts and locations

Locations

  • CH Victor Provot, Roubaix

    Roubaix, France

  • CH de Béthune

    Béthune, France

  • CH de Loos

    Loos, France

  • CH de Tourcoing

    Tourcoing, France

  • CH de Wattrelos

    Wattrelos, France

  • Centre hospitalier de béthune

    Béthune, France

  • Hôpital Calmette, CHU

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.